Analysis of perfusates during hypothermic machine perfusion by NMR spectroscopy: A potential tool for predicting kidney graft outcome

Transplantation

Volumn 97, Issue 8, 2014, Pages 810-816

  Bon, Delphine ^a,b   Claire, Billault ^c   Thuillier, Raphaël ^a,b,d,e   Hebrard, William ^f   Boildieu, Nadège ^a,b   Celhay, Olivier ^e   Irani, Jacques ^e   Seguin, François ^a,b   Hauet, Thierry ^a,b,c,d  

^a UNIVERSITÉ DE POITIERS   (France)

^b INSERM   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d COPE: Consortium for Organ Preservation in Europe ^*  (United Kingdom)

^e POITIERS UNIVERSITY HOSPITAL   (France)

^f CEMAGREF   (France)

Author keywords

Graft outcome; Kidney transplantation; Metabonomic; Nuclear magnetic resonance spectroscopy; Prognostic tool

Indexed keywords

AMINO ACIDS; ANIMALS; BIOLOGICAL MARKERS; CHOLINE; GLUTATHIONE; GRAFT SURVIVAL; HYPOTHERMIA, INDUCED; KIDNEY; KIDNEY TRANSPLANTATION; LACTIC ACID; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOMICS; MODELS, ANIMAL; PERFUSION; PREDICTIVE VALUE OF TESTS; SUS SCROFA; TRANSPLANTATION, AUTOLOGOUS; WARM ISCHEMIA;

EID: 84899474209     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000046     Document Type: Article

References (39)

1. Roels L, Rahmel A. The European experience. Transpl Int 2011; 24: 350.
2. Moers C, Smits JM, Maathuis MH, et al. Machine perfusion or coldstorage in deceased-donor kidney transplantation. N Engl J Med 2009;360: 7.
3. Stratta RJ, Moore PS, Farney AC, et al. Influence of pulsatile perfusionpreservation on outcomes in kidney transplantation from expandedcriteria donors. J Am Coll Surg 2007; 204: 873.
4. Yuan X, Theruvath AJ, Ge X, et al. Machine perfusion or cold storagein organ transplantation: indication, mechanisms, and future perspectives.Transpl Int 2010; 23: 561.
5. Bathini V, McGregor T, McAlister VC, et al. Renal perfusion pumpversus cold storage for donation after cardiac death kidneys: a systematicreview. J Urol 2013; 189: 2214.
6. Balfoussia D, Yerrakalva D, Hamaoui K, et al. Advances in machineperfusion graft viability assessment in kidney, liver, pancreas, lung,and heart transplant. Exp Clin Transplant 2012; 10: 87.
7. Matsuno N, Konno O,Mejit A, et al. Application of machine perfusionpreservation as a viability test for marginal kidney graft. Transplantation2006; 82: 1425.
8. Matsuno N, Kozaki K, Degawa H, et al. A useful predictor in machineperfusion preservation for kidney transplantation from non-heartbeatingdonors. Transplant Proc 2000; 32: 173.
9. MozesMF, SkolekRB, Korf BC.Use of perfusion parameters in predictingoutcomes of machine-preserved kidneys. Transplant Proc 2005; 37: 350.
10. Hoogland ER, de Vries EE, Christiaans MH, et al. The value of machineperfusion biomarker concentration in DCD kidney transplantations. Transplantation 2013; 95: 603.
11. Moers C, Varnav OC, van Heurn E, et al. The value of machine perfusionperfusate biomarkers for predicting kidney transplant outcome.Transplantation 2010; 90: 966.
12. Siew ED, Ware LB, Ikizler TA. Biological markers of acute kidneyinjury. J Am Soc Nephrol 2011; 22: 810.
13. Gowda GA, Tayyari F, Ye T, et al. Quantitative analysis of blood plasma metabolitesusing isotope enhanced NMR methods. Anal Chem 2010; 82: 8983.
14. McClay JL, Adkins DE, Isern NG, et al. (1)H nuclear magnetic resonancemetabolomics analysis identifies novel urinary biomarkers forlung function. J Proteome Res 2010; 9: 3083.
15. Codas R, Thuillier R, Hauet T, et al. Renoprotective effect of pulsatileperfusion machine RM3: pathophysiological and kidney injury biomarkercharacterization in a preclinical model of autotransplantedpig. BJU Int 2012; 109: 141.
16. Giraud S, Favreau F, Chatauret N, et al. Contribution of large pig forrenal ischemia-reperfusion and transplantation studies: the preclinicalmodel. J Biomed Biotechnol 2011; 2011: 532127.
17. Vekemans K, Liu Q, Heedfeld V, et al. Hypothermic liver machine perfusionwith EKPS-1 solution vs Aqix RS-I solution: in vivo feasibilitystudy in a pig transplantation model. Transplant Proc 2009; 41: 617.
18. Nicholson JK, Lindon JC, Holmes E. 'Metabonomics': understandingthe metabolic responses of living systems to pathophysiologicalstimuli via multivariate statistical analysis of biological NMR spectroscopicdata. Xenobiotica 1999; 29: 1181.
19. Rocha CM, Carrola J, Barros AS, et al. Metabolic signatures of lungcancer in biofluids: NMR-based metabonomics of blood plasma.J Proteome Res 2011; 10: 4314.
20. Xu J, Zhang J, Cai S, et al. Metabonomics studies of intact hepatic andrenal cortical tissues from diabetic db/db mice using high-resolutionmagic- angle spinning 1H NMR spectroscopy. Anal Bioanal Chem2009; 393: 1657.
21. Feng J, Liu H, Bhakoo KK, et al. A metabonomic analysis of organspecific response to USPIO administration. Biomaterials 2011; 32: 6558.
22. LiuQ, Vekemans K, van Pelt J, et al. Discriminate liver warm ischemic injuryduring hypothermic machine perfusion by proton magnetic resonancespectroscopy: a study in a porcine model. Transplant Proc 2009; 41: 3383.
23. Lindon JC, Nicholson JK, Holmes E, et al. Summary recommendationsfor standardization and reporting of metabolic analyses. NatBiotechnol 2005; 23: 833.
24. Rubtsov D, Jenkins H, Ludwig C, et al. Proposed reporting requirementsfor the description of NMR-based metabolomics experiments.Metabolomics 2007; 3: 223.
25. Sumner L, Amberg A, Barrett D, et al. Proposed minimum reportingstandards for chemical analysis. Metabolomics 2007; 3: 211.
26. Snoeijs MG, Pulinx B, van Dieijen-Visser MP, et al. Characterization ofthe perfusate proteome of human donor kidneys. Ann Clin Biochem2013; 50(Pt 2): 140.
27. Bhangoo RS, Hall IE, Reese PP, et al. Deceased-donor kidney perfusateand urine biomarkers for kidney allograft outcomes: a systematic review.Nephrol Dial Transplant 2012; 27: 3305.
28. Tietze IN, Sorensen SS, Eiskjaer H, et al. Tubular handling of aminoacids after intravenous infusion of amino acids in healthy humans.Nephrol Dial Transplant 1992; 7: 493.
29. Hauet T, Goujon JM, Vandewalle A, et al. Trimetazidine reduces renaldysfunction by limiting the cold ischemia/reperfusion injury inautotransplanted pig kidneys. J Am Soc Nephrol 2000; 11: 138.
30. Hauet T, Baumert H,GibelinH, et al.Noninvasivemonitoring of citrate,acetate, lactate, and renal medullary osmolyte excretion in urine asbiomarkers of exposure to ischemic reperfusion injury. Cryobiology2000; 41: 280.
31. Lash LH. Role of glutathione transport processes in kidney function.Toxicol Appl Pharmacol 2005; 204: 329.
32. Kievit JK, Nederstigt AP, Oomen AP, et al. Release of alpha-glutathioneS-transferase (alpha GST) and pi-glutathione S-transferase (pi GST)from ischemic damaged kidneys into the machine perfusateVrelevanceto viability assessment. Transplant Proc 1997; 29: 3591.
33. van Smaalen TC, Hoogland ER, van Heurn LW. Machine perfusionviability testing. Curr Opin Organ Transplant 2013; 18: 168.
34. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu RevPharmacol Toxicol 2005; 45: 51.
35. Beckonert O, Keun HC, Ebbels TM, et al. Metabolic profiling,metabolomic and metabonomic procedures for NMR spectroscopy ofurine, plasma, serum and tissue extracts. Nat Protoc 2007; 2: 2692.
36. Haller M, Gutjahr G, Kramar R, et al. Cost-effectiveness analysis of renalreplacement therapy in Austria. Nephrol Dial Transplant. 2011; 26: 298.
37. Blotiere PO, Tuppin P, Weill A, et al. [The cost of dialysis and kidneytransplantation in France in 2007, impact of an increase of peritonealdialysis and transplantation]. Nephrol Ther 2010; 6: 240.
38. Giraud S, Thuillier R, Belliard A, et al. Direct thrombin inhibitorprevents delayed graft function in a porcine model of renal transplantation.Transplantation 2009; 87: 1636.
39. Silvestre V, Goupry S, Trierweiler M, et al. Determination of substrateand product concentrations in lactic acid bacterial fermentations byproton NMR using the ERETIC method. Anal Chem 2001; 73: 1862.